Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
A Systematic Review of the Risks of Stroke & Death Due to Endarterectomy for Symptomatic Carotid Stenosis
Stroke 27:260-265, Rothwell,P.M.,et al, 1996
A Systematic Comparison of Risks of Stroke & Death Due to Carotid Endarterectomy for Symptomatic & Asympt Stenosis
Stroke 27:266-269, Rothwell,P.M.,et al, 1996
Gait Disorders in Older Adults
J Am Geriatr Soc 44:434-452, Alexander,N.B., 1996
Role of Stroke Rehabilitation Units in Managing Severe Disability after Stroke
Stroke 26:2031-2034, Kalra,L.&Eade,J., 1995
The Eosinophilia-Myalgia Syndrome:Status of 205 Patients and Results of Treatment 2 Years After Onset
Ann Int Med 122:851-855, Hertzman,P.A.,et al, 1995
Improvement of Multifocal Motor Neuropathy During Long-Term Weekly Treatment with Human Immunoglobulin
Neurol 45:987-988, van den Berg,L.H.,et al, 1995
Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995
Diagnostic Yield of the Neurologic Assessment of the Developmentally Delayed Child
J Pediatr 127:193-199, Majnemer,A.&Shevell,M.I., 1995
Surgical Management of Spinal Epidural Hematoma:Relationship Between Surgical Timing and Neurological Outcome
J Neurosurg 83:1-7, Lawton,M.T.,et al, 1995
Cerebrospinal Fluid
JNNP 59:349-357, Thompson,E.J., 1995
The Effect of a Stroke Unit:Reductions in Mortality, Discharge Rate to Nursing Home, Length of Hospital Stay and Cost
Stroke 26:1178-1182, Jorgensen,H.S.,et al, 1995
Medical Complications During Stroke Rehabilitation
Stroke 26:990-994, Kalra,L.,et al, 1995
Association Between Trigeminal Neuralgia and Multiple Sclerosis:Role of Magnetic Resonance Imaging
JNNP 59:253-259, Meaney,J.F.M.,et al, 1995
Reflex Sympathetic Dystrophy
BMJ 310:1645-1648, Paice,E., 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Mild Traumatic Brain Injury:Pathophysiology, Natural History, and Clinical Management
Neurol 45:1253-1260, 12511995., Alexander,M.P., 1995
Therapeutic Considerations in Patients with Refractory Neurosarcoidosis
Arch Neurol 52:875-879, Agbogu,B.N.,et al, 1995
Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995
Optic Neuritis:A Population-Based Study in Olmsted County, Minnesota
Neurol 45:244-250, Rodriquez,M.,et al, 1995
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
The Natural History of Progressive Mutlifocal Leukoencephalopathy in Patients with AIDS
Clin Inf Dis 20:1305-1310, Fong,I.W.,et al, 1995
Canavan Disease:From Spongy Degeneration to Molecular Analysis
J Pediatr 127:511-517, Matalon,R.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994
Is Stroke Better Managed in the Community
BMJ 309:1356-1358, Young,J., 1994
So Stroke Units Save Lives:Where Do We Go From Here
BMJ 309:1273-1277, Dennis,M.&Langhorne,P., 1994
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994
The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994
Head Injury in Sport
BMJ 308:1620-1624, McLatchie,G.&Jennett,B., 1994
Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994
The Infant or Young Child with Developmental Delay
NEJM 330:478-483, First,L.R.&Palfrey,J.S., 1994
A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994
Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994
Influence of Stroke Unit Rehabilitation on Functional Recovery from Stroke
Stroke 25:821-825, Kalra,L., 1994
Assessment of Neurological Prognosis in Comatose Survivors of Cardiac Arrest
Lancet 343:1055-1059, Edgren,E.,et al, 1994
Prevention of Functional Impairment by Endarterectomy for Symptomatic High-Grade Carotid Stenosis
JAMA 271:1256-1259, Haynes,R.B.,et al, 1994
Cost of Acute Stroke Care in Toronto, Canada
Stroke 25:1628-1631, Smurawska,L.T.,et al, 1994
Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994